An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer.

Andrew John SuttonJohn V LamontR Mark EvansKate WilliamsonDeclan O'RourkeBrian DugganGurdeep S SagooCherith N ReidMark W Ruddock

Published in: PloS one (2018)

This analysis shows the potential for a non-invasive test to be added to the diagnostic pathway for haematuria patients suspected of having UBC. If the DCRSHP is applied targeting haematuria patients at low risk of UBC, then it has the potential to be both effective and cost-effective.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
risk assessment
patient reported outcomes